S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
S&P 500   2,631.84 (+5.75%)
DOW   22,317.11 (+6.01%)
QQQ   194.18 (+5.90%)
AAPL   255.93 (+6.01%)
FB   164.16 (+6.47%)
MSFT   161.98 (+5.30%)
GOOGL   1,169.50 (+7.03%)
AMZN   1,977.65 (+3.73%)
CGC   14.22 (+7.24%)
NVDA   263.57 (+8.06%)
BABA   195.96 (+4.73%)
GE   7.15 (+6.09%)
TSLA   509.20 (+6.08%)
AMD   46.38 (+8.90%)
ACB   0.82 (+1.24%)
F   4.50 (+5.89%)
NFLX   376.63 (+4.11%)
BAC   21.13 (+5.49%)
GILD   76.25 (-2.51%)
DIS   98.10 (+4.50%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 DermTechAnpac Bio-Medical ScienceEnzo BiochemCelcuityCentogene
SymbolNASDAQ:DMTKNASDAQ:ANPCNYSE:ENZNASDAQ:CELCNASDAQ:CNTG
Price Information
Current Price$10.77$7.60$2.39$5.98$19.03
52 Week RangeBuyN/AN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyN/AN/ABuyBuy
Consensus Price Target$24.00N/AN/A$19.00$16.67
% Upside from Price Target122.84% upsideN/AN/A217.73% upside-12.42% downside
Trade Information
Market Cap$160.17 million$85.12 million$117.24 million$60.99 million$350.53 million
Beta0.74N/A0.681.02N/A
Average Volume59,1021,8361,573,82719,87829,976
Sales & Book Value
Annual Revenue$3.36 millionN/A$81.17 millionN/A$47.81 million
Price / Sales47.57N/A1.40N/A7.90
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.01 per shareN/A$1.81 per share$1.88 per shareN/A
Price / Book10.66N/A1.32N/A∞
Profitability
Net Income$-19,690,000.00N/A$2.49 million$-7,360,000.00$-12,950,000.00
EPSN/AN/AN/A($0.72)N/A
Trailing P/E Ratio0.000.0059.76N/A0.00
Forward P/E Ratio∞∞∞∞N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A1.92%N/AN/A
Return on Equity (ROE)-81.72%N/A-31.31%-34.12%N/A
Return on Assets (ROA)-52.28%N/A-22.22%-32.56%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.32%N/A1.44%
Current Ratio3.00%N/A3.06%21.13%0.82%
Quick Ratio2.99%N/A2.74%21.13%0.77%
Ownership Information
Institutional Ownership Percentage24.93%N/A67.75%21.77%8.28%
Insider Ownership Percentage21.00%N/A9.40%43.50%N/A
Miscellaneous
Employees36N/A46026400
Shares Outstanding14.84 million11.20 million47.56 million10.25 million19.86 million
Next Earnings DateN/AN/A6/8/2020 (Estimated)5/5/2020 (Estimated)N/A
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel